Skip to main content Accessibility help
×
×
Home

In search of black bile

  • Brian E Leonard (a1)

Extract

Historically Western medicine has been divided into two main schools that were based on the ancient Greek tradition. These are the Hygeian school, based on the views of Hippocrates (born 460 BC), and the Asclepian school which is named after the Greek god of medicine but probably based on the physician Asclepius who was said to have performed miracles!

In brief, the Hygeian school of medicine views health as a natural state of the body. The body is believed to be endowed with inherent healing powers which, if one lives in harmony with these powers, maintains health and helps to restore it should it become impaired. Disease is seen as a manifestation of a weakness of the inherent healing powers of the body and the function of the physician is to help the patients to live within the natural law (vis medicatrix naturae) and to remove impediments to those mechanisms that maintain and restore health.

The second school that has profoundly influenced the development of modern medicine is the Asclepian school which arose in about 1200 BC around the teaching of Asclepius. This school focuses on diseases, their causes and cures. Each disease is considered to be the effect of, or response to, a specific cause that primarily affects a specific organ system. For every disease it is postulated that there is a specific drug or procedure which can alleviate the symptoms or cure the disease. Thus, the successful physician is the one who can make the correct diagnosis and prescribe the correct therapy.

Copyright

References

Hide All
1.Early Greek and Roman Medicine. Encyclopaedia Britannica 1983; 11:826–7.
2.Still, AT. Autobiography, Kirksville, Missouri 1897; 100.
3.Leonard, BE. The effect of chronic administration of barbitone sodium on chemically and electrically induced convulsions in the rat. Int J Neuropharmac 1968; 7:463–9.
4.Riddell, D, Leonard, BE. Some effects of a coma producing material obtained from mammalian brain. Neuropharmac 1970; 9:283–99.
5.Leonard, BE, Riddell, D. Neurochemical effects of a coma producing material from mammalian brain. Neuropharmac 1970; 9:489–96.
6.Lai, H, La Bella, F, Lane, J. Preface In: Endocoids (Eds. Lai, H, La Bella, F, Lane, J). Alan R Liss Inc., New York, 1985; xxi.
7.Hughe, J, Smith, TW, Kosterlitz, HW. Identification of two related pentapetides from the brain with potent opiate agonist activity. Nature, 258:577.
8.Costa, E, Guidotti, A. Molecular mechanism in the receptor action of benzodiazepines. Ann Rev Phararmac 1979; 19:531–45.
Asano, JT. and Spector, S. Identification of inosine and hypoxanthine as endogenous ligands for brain benzodiazepine binding sites. Proc Natl Acad Sci 1978;76:977–81.
10.Mohler, H, Pole, P, Cummin, R, Pieri, L, Kettler, R. Nicotinamide is a brain constituent with benzodiazepine like actions. Nature 1979; 278:563–5.
11.De Bias, AL, Sotelo, C. Localization of benzodiazepine-like molecules in the rat brain. A light and election microscopy immunocytochemistry study with an antibenzodiazepine monoclonal antibody. Brain Res; 413:285–96.
12.Schofield, PR, Darlison, MG, Fujita, N. Sequence and functional expression of the GABA A receptor shows a ligand gated receptor superfamily. Nature 1987; 328:221–7.
13.Haefely, W. Actions and interactians of benzodiazepine agonists and antagonists at GABAergic synapses. In: Actions and interactions of GABA and benzodiazepine. (Ed. Bawery, NG, Raven Press, New York, 1984; 263–85.
14.Muller, WE. The benzodiazepine receptor. Cambridge University Press, Cambridge 1987; 7896 (1987).
15.Kennedy, B, Leonard, BE. Similarity between the action of nicotinamide and diazepam on neurotransmitter metabolism in the rat. Biochem Soc Trans 1980; 8:5961.
16.Braestrup, C, Nielsen, M, Olsen, CE. Urinary and brain beta carboline 3 carboxylates as potent inhibitor of brain benzodiazepine receptors. Proc Nat Acad Sci 1988;77:2288–92.
17.De Blas, AL. Benzodiazepines and benzodiazepine-like molecules are present in brain. In: Naturally occurring Benzodiazepines. (Eds: Izquierdo, I, Medina, J.). Ellis Horwood, New York 1993; 127.
18.Luckner, M. Secondary metabolism in microorganisms, plants and animals. 2nd Edition. Springer-Verlag, Berlin 1984; 272–6.
19.Basile, AS, Gammal, S. The involvement of benzodiazepine receptors in hepatic encephalopathy: implications for treatment with benzodiazepine receptor antagonists. Clinical Neuropharm 1988;11: 401–22.
20.Mullen, KD, Mendelson, WB, Martin, JV; Roeslle, M. Could an endogenous benzodiazepine ligand contribute to hepatic encephalopathy? In: Naturally Occurring Benzodiazepines. (Eds. Izquierdo, I, Medina, J.Ellis Horwood, New York 1993; 89114.
21.Basile, AS. The role of benzodiazepine receptor ligand in the pathogenesis of hepatic encephalopathy. In: Naturally Occurring Benzodiazepines. (Eds. Izquierdo, I, Medina, J.Ellis Horwood, New York 1993; 89114.
22.Cultural Areas. Encyclopaedia Britannica 1983; 5: 365.
23.Brusov, OS, Beliaev, BS, Katasonov, AB, Zlobaina, GP. Does platelet serotonin receptor supersensitivity accompany endogenous depression? Biol Psychiat 1989; 25:375–81.
24.Healy, D, Carney, PA, Leonard, BE. Monoamine related markers of depression. J Psychiat Res; 17:251–8.
25.Healy, D, Carney, PA, O'Halloran, A, Leonard, BE. Peripheral adrenoceptors and sorotonin receptors in depression. J Affect Dis 1985; 17:285–92.
26.Roth, BL, Nakaki, T, Chaune, DM, Costa, E. Evidence for an endocoid for the 5HT2 recognition site. Prog Clin Biol Res 1985;192:473–6.
27.McAdams, C, Leonard, BE. Changes in platelet aggregatory responses to collagen and 5-hydroxy tryptamine in depressed schizophrenic and manic patients. Int Clin Psychopharmac 1992; 7:81–5.
28.Nugent, DF, Dinan, TG, Leonard, BE. Alteration by a plasma factor(s) of platelet aggregation in ummedicated unipolar depressed patients. J Affect Dis 1994; 31:61–6.
29.Calabrese, J, Skwereer, RG, Barna, B. Depression, immunocompetence and prostaglandins of the E series. Psychiat Res 1986;17:44–7.
30.Krup, P, Wesp, W. Inhibition of prostaglandin synthetase by psychotropic drugs. Experientia 1975; 31:330–6.
31.Tang, SW, Cheung, S, Strijewski, A, Chudzik, J. Anti-imipramine antibodies recognize endogenous serotonin uptake and imipramine binding inhibitors. Psychiat Res 1990; 34:205–12.
32.McAdams, C, Colohan, F, Brophy, J, Leonard, BE. Alteration by a plasma factor of platelet aggregation and 5HT uptake in depression. Biol Psychiat 1992; 32:296–8.
33.Leonard, BE. In search for black bile: do antidepressants act by changing endogenous endocoids in the depressed patient? J Psychopharmac 1993; 7:13.
34.Takeuchi, Y, Root-Bernstein, RS, Shih, JC. Peptide displacement of 3H-5-hydroxytryptamine to bovine cortical membranes. Brain Res Bull 1990;25:817–20.
35.Gruber, KA, Klein, MC, Lymangrover, JR. Natriuretic peptides derived from pro-opioocortin. In: Endocoids. (Eds. Lal, H, La Bella, F, Lane, J). Alan R Liss, New York 1985; 213–20.
36.Valdes, R. Endogeous digoxin-immunoreacfive substances measured in several patient populations. Endocoids 1985; 221–8.
37.Smith, EM, Blalock, JE. Human lymphocyte production of ACTH and endorphin-like subtances: association with leucocyte interferon. Proc Natl Acad Sci, USA 1981;78:7530–4.
38.Dafny, N. Interferon as an endocoid candidate preventing and attenuating opiate addition. In: Endocoids. (Eds. Lal, H, La Bella, F, Lane, J). Alan R Liss, New York 1985; 269–76.
39.Zetler, G. Neuropharmacological profile of cholecystokinin-like peptides. Ann NY Acad Sci 1985; 448:448–69.
40.Sandler, M. Benzodiazepines: studies on a possible endogenous ligand. In: Benzodiazepines Divided. (Ed. Trimble, M.) John Wiley and Sons, Chichester 1983; 139–47.
41.Koob, FG, Thatcher, BK, Tazi, A, Le, MM. Behavioural pharmacology of stress: focus on CNS corticotorphin releasing factor. Adv Exp Med Biol 1988; 245:2534.
42.Richie, JC, Nemeroff, CB. Stress, the hypothalamic-pituitary-adrenal axis and depression. In: Stress, Neuropeptides and Systemic Disease. (Eds. McCubbin, JA, Kaufmann, PG, Nemeroff, CB) Academic Press, New York 1991; 181–97.
43.Contreras, PCD, Maggio, DA, O'Donohue, TL. Evidence for an endogenous peptide ligand and antagonist for PCP receptors. In: Endocoids. (Eds. lal, H, La Bella, F, Lane, T.) Alan R. Liss Inc., New York 1985; 495–8.
44.Nemeroff, CB. Neurotensin: perchance an endogenous neuroleptic? Biol Psychiat 1980;15:283302.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Irish Journal of Psychological Medicine
  • ISSN: 0790-9667
  • EISSN: 2051-6967
  • URL: /core/journals/irish-journal-of-psychological-medicine
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed